{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:06:45Z","timestamp":1787677605081,"version":"build-2784847793"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.jvir.2012.03.002","type":"journal-article","created":{"date-parts":[[2012,4,25]],"date-time":"2012-04-25T02:16:53Z","timestamp":1335320213000},"page":"770-777","source":"Crossref","is-referenced-by-count":85,"title":["Percutaneous Cryoablation of Metastatic Renal Cell Carcinoma for Local Tumor Control: Feasibility, Outcomes, and Estimated Cost-effectiveness for Palliation"],"prefix":"10.1016","volume":"23","author":[{"given":"Hyun J.","family":"Bang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Littrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan J.","family":"Goodrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandt P.","family":"Currier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein D.","family":"Aoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance K.","family":"Heilbrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulka","family":"Vaishampayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen C.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2012.03.002_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jvir.2012.03.002_bib2","first-page":"1","article-title":"Current management of advanced and metastatic renal cell carcinoma","volume":"7","author":"Ather","year":"2010","journal-title":"Urol J"},{"key":"10.1016\/j.jvir.2012.03.002_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14020","article-title":"Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation","volume":"14","author":"Thompson-Coon","year":"2010","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jvir.2012.03.002_bib4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJM198701293160505","article-title":"Decision analysis","volume":"316","author":"Pauker","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvir.2012.03.002_bib5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa021491","article-title":"A randomised trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer","volume":"349","author":"Yang","year":"2003","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jvir.2012.03.002_bib6","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/S0140-6736(07)61904-7","article-title":"Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial","volume":"370","author":"Escudier","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jvir.2012.03.002_bib7","doi-asserted-by":"crossref","unstructured":"Rini BI, Halabi S, Rosenberg JE, et al. CALGB 90206: a phase III trial of bevacizumab plus interferon-alpha versus interferon-alpha monotherapy in metastatic renal cell carcinoma. In: 2008 ASCO Genitourinary Cancers Symposium Proceedings. Abstract 350.","DOI":"10.1200\/jco.2009.27.18_suppl.lba5019"},{"key":"10.1016\/j.jvir.2012.03.002_bib8","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.ejca.2008.06.028","article-title":"Recent advances in the treatment of renal cell carcinoma and the role of targeted therapies","volume":"44","author":"Chowdhury","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jvir.2012.03.002_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.eururo.2005.03.004","article-title":"Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma","volume":"48","author":"Hofmann","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.jvir.2012.03.002_bib10","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.juro.2008.05.006","article-title":"Risk score and metastasectomy independently impact prognosis in patients with recurrent renal cell carcinoma","volume":"180","author":"Eggener","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.jvir.2012.03.002_bib11","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jtcvs.2003.11.016","article-title":"Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue sarcoma: a combined analysis from the University of Texas M. D. Anderson and Memorial Sloan-Kettering Cancer Centers","volume":"127","author":"Porter","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jvir.2012.03.002_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.eururo.2008.12.026","article-title":"Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients","volume":"57","author":"Naito","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.jvir.2012.03.002_bib13","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1148\/radiol.2533091286","article-title":"Comparative effectiveness research: What it means for radiology","volume":"253","author":"Pandharipande","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2012.03.002_bib14","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1148\/radiol.2371040829","article-title":"Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation--initial observations","volume":"237","author":"Allaf","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2012.03.002_bib15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jvir.2006.12.007","article-title":"CT-guided percutaneous cryotherapy of renal masses","volume":"18","author":"Littrup","year":"2007","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2012.03.002_bib16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1148\/radiol.2351030747","article-title":"Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures","volume":"235","author":"Wang","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2012.03.002_bib17","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.jvir.2009.06.029","article-title":"Cryotherapy for breast cancer: a feasibility study without excision","volume":"20","author":"Littrup","year":"2009","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2012.03.002_bib18","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jvir.2009.05.038","article-title":"Lethal isotherms of cryoablation in a phantom study: effects of heat load, probe size, and number","volume":"20","author":"Littrup","year":"2009","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2012.03.002_bib19","series-title":"Statistical methods for survival data analysis","author":"Lee","year":"2003"},{"key":"10.1016\/j.jvir.2012.03.002_bib20","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1148\/radiol.10092013","article-title":"Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis","volume":"256","author":"Pandharipande","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2012.03.002_bib21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1148\/radiol.2481071448","article-title":"Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis","volume":"248","author":"Pandharipande","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2012.03.002_bib22","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1148\/radiol.2333032052","article-title":"Metastatic colorectal carcinoma: cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection","volume":"233","author":"Gazelle","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2012.03.002_bib23","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.urology.2009.06.058","article-title":"Radio-frequency ablation of solitary adrenal gland metastasis from renal cell carcinoma","volume":"74","author":"Mouracade","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.jvir.2012.03.002_bib24","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2214\/AJR.09.3561","article-title":"Imaging-guided percutaneous radiofrequency ablation of retroperitoneal metastatic disease in patients with gynecologic malignancies: clinical experience with eight patients","volume":"194","author":"Arellano","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jvir.2012.03.002_bib25","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1148\/radiol.2431060088","article-title":"Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients","volume":"243","author":"Simon","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2012.03.002_bib26","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1470-2045(08)70155-4","article-title":"Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study)","volume":"9","author":"Lencioni","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jvir.2012.03.002_bib27","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1464-410X.2009.08459.x","article-title":"Percutaneous radiofrequency ablation for unresectable pulmonary metastases from renal cell carcinoma","volume":"104","author":"Soga","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.jvir.2012.03.002_bib28","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1245\/s10434-009-0664-5","article-title":"Use of percutaneous radiofrequency ablation in pulmonary metastases from renal cell carcinoma","volume":"16","author":"Shu Yan Huo","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jvir.2012.03.002_bib29","series-title":"The Economics of Health and Health Care","first-page":"74","article-title":"Cost benefit analysis and other tools of economic evaluation","author":"Folland","year":"2010"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044312003016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044312003016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T22:04:25Z","timestamp":1561673065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044312003016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1051044312003016"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2012.03.002","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}